These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 24457404

  • 1. Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Delkos D, Tsourdi EA, Panidis D.
    Hormones (Athens); 2013; 12(4):559-66. PubMed ID: 24457404
    [Abstract] [Full Text] [Related]

  • 2. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.
    Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D.
    Endocr J; 2011; 58(4):237-46. PubMed ID: 21325745
    [Abstract] [Full Text] [Related]

  • 3. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.
    Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
    [Abstract] [Full Text] [Related]

  • 4. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
    Song J, Ruan X, Gu M, Wang L, Wang H, Mueck AO.
    Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.
    Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, Guvener N.
    Diabetes Obes Metab; 2002 Jan; 4(1):49-55. PubMed ID: 11874442
    [Abstract] [Full Text] [Related]

  • 6. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 7. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]

  • 8. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 9. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M, Yang M, Zhou X, Fang X, Hu W, Zhu W, Wang C, Liu D, Li S, Liu H, Yang G, Li L.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [Abstract] [Full Text] [Related]

  • 10. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [Abstract] [Full Text] [Related]

  • 11. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 12. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 13. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.
    Velazquez EM, Mendoza SG, Wang P, Glueck CJ.
    Metabolism; 1997 Apr; 46(4):454-7. PubMed ID: 9109854
    [Abstract] [Full Text] [Related]

  • 14. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.
    Vosnakis C, Georgopoulos NA, Armeni AK, Papadakis E, Roupas ND, Katsikis I, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):185-9. PubMed ID: 22579228
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 16. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis.
    Graff SK, Mario FM, Ziegelmann P, Spritzer PM.
    Int J Clin Pract; 2016 Jun; 70(6):450-61. PubMed ID: 27228266
    [Abstract] [Full Text] [Related]

  • 17. [Effects of orlistat and metformin on metabolism and gonadal function in overweight or obese patients with polycystic ovary syndrome].
    Zhao YX, Wang LJ, Gong FY, Pan H, Miao H, Duan L, Yang HB, Zhu HJ.
    Zhonghua Nei Ke Za Zhi; 2021 Dec 01; 60(12):1165-1168. PubMed ID: 34856689
    [Abstract] [Full Text] [Related]

  • 18. Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
    Sari R, Balci MK, Cakir M, Altunbas H, Karayalcin U.
    Endocr Res; 2004 May 01; 30(2):159-67. PubMed ID: 15473126
    [Abstract] [Full Text] [Related]

  • 19. Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
    Ruan X, Song J, Gu M, Wang L, Wang H, Mueck AO.
    Arch Gynecol Obstet; 2018 Jun 01; 297(6):1557-1563. PubMed ID: 29602978
    [Abstract] [Full Text] [Related]

  • 20. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
    Leung WY, Thomas GN, Chan JC, Tomlinson B.
    Clin Ther; 2003 Jan 01; 25(1):58-80. PubMed ID: 12637112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.